BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

951 related articles for article (PubMed ID: 24398338)

  • 21. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.
    Zhong YM; Liu WE; Liang XH; Li YM; Jian ZJ; Hawkey PM
    J Antimicrob Chemother; 2015 Aug; 70(8):2223-7. PubMed ID: 25957581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.
    Namaei MH; Yousefi M; Ziaee M; Salehabadi A; Ghannadkafi M; Amini E; Askari P
    Microb Drug Resist; 2017 Oct; 23(7):879-884. PubMed ID: 28437226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins.
    Hammerum AM; Larsen J; Andersen VD; Lester CH; Skovgaard Skytte TS; Hansen F; Olsen SS; Mordhorst H; Skov RL; Aarestrup FM; Agersø Y
    J Antimicrob Chemother; 2014 Oct; 69(10):2650-7. PubMed ID: 24908045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
    Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains.
    Blanc V; Leflon-Guibout V; Blanco J; Haenni M; Madec JY; Rafignon G; Bruno P; Mora A; Lopez C; Dahbi G; Dunais B; Anastay M; Branger C; Moreau R; Pradier C; Nicolas-Chanoine MH
    J Antimicrob Chemother; 2014 May; 69(5):1231-7. PubMed ID: 24402502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15.
    Park SH; Byun JH; Choi SM; Lee DG; Kim SH; Kwon JC; Park C; Choi JH; Yoo JH
    BMC Infect Dis; 2012 Jun; 12():149. PubMed ID: 22747570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal Carriage of Extended-Spectrum β-Lactamases in Healthy Humans, Poultry, and Wild Birds in León, Nicaragua-A Shared Pool of bla
    Hasan B; Laurell K; Rakib MM; Ahlstedt E; Hernandez J; Caceres M; Järhult JD
    Microb Drug Resist; 2016 Dec; 22(8):682-687. PubMed ID: 27007258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence and characteristics of extended-spectrum-β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses.
    Dierikx CM; van Duijkeren E; Schoormans AH; van Essen-Zandbergen A; Veldman K; Kant A; Huijsdens XW; van der Zwaluw K; Wagenaar JA; Mevius DJ
    J Antimicrob Chemother; 2012 Jun; 67(6):1368-74. PubMed ID: 22382469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IncI1 plasmids carrying bla(CTX-M-1) or bla(CMY-2) genes in Escherichia coli from healthy humans and animals in Tunisia.
    Ben Sallem R; Ben Slama K; Rojo-Bezares B; Porres-Osante N; Jouini A; Klibi N; Boudabous A; Sáenz Y; Torres C
    Microb Drug Resist; 2014 Oct; 20(5):495-500. PubMed ID: 24826863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.
    Matsumura Y; Johnson JR; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S; ;
    J Antimicrob Chemother; 2015; 70(6):1639-49. PubMed ID: 25687644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug resistance dissemination by extended-spectrum β-lactamase-producing Escherichia coli causing community-acquired urinary tract infection in the Central-Western Region, Brazil.
    Gonçalves LF; de Oliveira Martins-Júnior P; de Melo ABF; da Silva RCRM; de Paulo Martins V; Pitondo-Silva A; de Campos TA
    J Glob Antimicrob Resist; 2016 Sep; 6():1-4. PubMed ID: 27530830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase of widespread A, B1 and D Escherichia coli clones producing a high diversity of CTX-M-types in a Portuguese hospital.
    Rodrigues C; Machado E; Pires J; Ramos H; Novais Â; Peixe L
    Future Microbiol; 2015; 10(7):1125-31. PubMed ID: 26119348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain.
    Rogers BA; Sidjabat HE; Paterson DL
    J Antimicrob Chemother; 2011 Jan; 66(1):1-14. PubMed ID: 21081548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
    Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
    Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial resistance, multilocus sequence types and virulence profiles of ESBL producing and non-ESBL producing uropathogenic Escherichia coli isolated from cats and dogs in Switzerland.
    Zogg AL; Zurfluh K; Schmitt S; Nüesch-Inderbinen M; Stephan R
    Vet Microbiol; 2018 Mar; 216():79-84. PubMed ID: 29519530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-genome sequences of multidrug-resistant Escherichia coli in South-Kivu Province, Democratic Republic of Congo: characterization of phylogenomic changes, virulence and resistance genes.
    Irenge LM; Ambroise J; Bearzatto B; Durant JF; Chirimwami RB; Gala JL
    BMC Infect Dis; 2019 Feb; 19(1):137. PubMed ID: 30744567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms.
    Van der Bij AK; Peirano G; Pitondo-Silva A; Pitout JD
    Diagn Microbiol Infect Dis; 2012 Apr; 72(4):297-302. PubMed ID: 22300954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b:H4-B2-ST131 and O25b:H4-D-ST69 in raw sewage and river water in Barcelona, Spain.
    Colomer-Lluch M; Mora A; López C; Mamani R; Dahbi G; Marzoa J; Herrera A; Viso S; Blanco JE; Blanco M; Alonso MP; Jofre J; Muniesa M; Blanco J
    J Antimicrob Chemother; 2013 Apr; 68(4):758-65. PubMed ID: 23221627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.